Literature DB >> 26589908

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.

Sylvia Ganghammer1, Julia Gutjahr1, Evelyn Hutterer1, Peter W Krenn1, Susanne Pucher1, Claudia Zelle-Rieser2, Karin Jöhrer2, Maikel Wijtmans3, Rob Leurs3, Martine J Smit3, Valter Gattei4, Richard Greil1, Tanja N Hartmann5.   

Abstract

Entities:  

Keywords:  B-cell receptor; CLL; CXCL12; chemokine; microenvironment

Mesh：

Substances：

Year:  2015        PMID： 26589908      PMCID： PMC4815737          DOI： 10.3324/haematol.2015.133470

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.

Authors:  Rajendra N Damle; Carlo Calissano; Nicholas Chiorazzi
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

2.  CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.

Authors:  Oliver Giegold; Nadine Ogrissek; Cornelia Richter; Matthias Schröder; Martina Herrero San Juan; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

3.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

4.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

5.  Potential role of serum level of soluble CD44 and IFN-γ in B-cell chronic lymphocytic leukemia.

Authors:  Nervana Samy; M D Abd El-Maksoud; T E Mousa; Hatem A El-Mezayen; Mohamed Shaalan
Journal:  Med Oncol       Date:  2010-08-31       Impact factor: 3.064

6.  CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

Authors:  Giovanni Del Poeta; Maria Ilaria Del Principe; Antonella Zucchetto; Fabrizio Luciano; Francesco Buccisano; Francesca Maria Rossi; Antonio Bruno; Annalisa Biagi; Pietro Bulian; Luca Maurillo; Benedetta Neri; Riccardo Bomben; Cristina Simotti; Angela Maria Coletta; Michele Dal Bo; Paolo de Fabritiis; Adriano Venditti; Valter Gattei; Sergio Amadori
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

7.  Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3.

Authors:  Danny J Scholten; Maikel Wijtmans; Jeffrey R van Senten; Hans Custers; Ailas Stunnenberg; Iwan J P de Esch; Martine J Smit; Rob Leurs
Journal:  Mol Pharmacol       Date:  2015-01-09       Impact factor: 4.436

8.  Cell Trafficking in Chronic Lymphocytic Leukemia.

Authors:  Matthew S Davids; Jan A Burger
Journal:  Open J Hematol       Date:  2012-02-21

9.  Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.

Authors:  A O Watts; M M H van Lipzig; W C Jaeger; R M Seeber; M van Zwam; J Vinet; M M C van der Lee; M Siderius; G J R Zaman; H W G M Boddeke; M J Smit; K D G Pfleger; R Leurs; H F Vischer
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

10.  CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.

Authors:  Sylvia Ganghammer; Evelyn Hutterer; Elisabeth Hinterseer; Gabriele Brachtl; Daniela Asslaber; Peter William Krenn; Tamara Girbl; Petra Berghammer; Roland Geisberger; Alexander Egle; Antonella Zucchetto; Anna Kruschinski; Valter Gattei; Alexandre Chigaev; Richard Greil; Tanja Nicole Hartmann
Journal:  Oncotarget       Date:  2015-05-20
View more
  11 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

2.  Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.

Authors:  Shi Hui Li; Wen Chuan Dong; Li Fan; Guang Sheng Wang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 3.  Molecular Players in Hematologic Tumor Cell Trafficking.

Authors:  Javier Redondo-Muñoz; Angeles García-Pardo; Joaquin Teixidó
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

4.  Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.

Authors:  Fangfang Chen; Jingping Yuan; Honglin Yan; Huan Liu; Shuai Yin
Journal:  Biomed Res Int       Date:  2019-05-21       Impact factor: 3.411

5.  Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.

Authors:  Valentina Bonanni; Fabrizio Antonangeli; Angela Santoni; Giovanni Bernardini
Journal:  J Immunother Cancer       Date:  2019-11-07       Impact factor: 13.751

Review 6.  MRI and PET/MRI in hematologic malignancies.

Authors:  Marius E Mayerhoefer; Stephen J Archibald; Christina Messiou; Anton Staudenherz; Dominik Berzaczy; Heiko Schöder
Journal:  J Magn Reson Imaging       Date:  2019-07-01       Impact factor: 4.813

7.  Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis.

Authors:  Patrizia Virdis; Rossana Migheli; Valentina Bordoni; Francesco Paolo Fiorentino; Luca Sanna; Irene Marchesi; Giorgio Pintore; Grazia Galleri; Maria Rosaria Muroni; Luigi Bagella; Claudio Fozza; Maria Rosaria De Miglio; Luigi Podda
Journal:  Int J Mol Med       Date:  2021-10-13       Impact factor: 4.101

8.  BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

Authors:  Andrea Haerzschel; Julie Catusse; Evelyn Hutterer; Manuela Paunovic; Katja Zirlik; Hermann Eibel; Peter W Krenn; Tanja N Hartmann; Meike Burger
Journal:  Ann Hematol       Date:  2016-08-20       Impact factor: 3.673

9.  High CXCR3 on Leukemic Cells Distinguishes IgHV mut from IgHV unmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones.

Authors:  Gayane Manukyan; Tomas Papajik; Zuzana Mikulkova; Renata Urbanova; Veronika Smotkova Kraiczova; Jakub Savara; Milos Kudelka; Peter Turcsanyi; Eva Kriegova
Journal:  J Immunol Res       Date:  2020-06-20       Impact factor: 4.818

10.  Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk.

Authors:  Julie E Feusier; Michael J Madsen; Brian J Avery; Justin A Williams; Deborah M Stephens; Boyu Hu; Afaf E G Osman; Martha J Glenn; Nicola J Camp
Journal:  J Transl Genet Genom       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.